Related Experiment Video
Updated: Jun 20, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Can aspirin protect or at least attenuate gentamicin ototoxicity in humans?
Fatholah Behnoud1, Khashayar Davoudpur, Mohammad T Goodarzi
1Department of Ear, Nose and Throat, Medical School, Hamadan University of Medical Sciences, Hamadan, Iran. behnoud344@yahoo.com
Objective:
To investigate and prove that Aspirin as an antioxidant protects, or at least attenuates Gentamicin ototoxicity in humans.
Methods:
A prospective, randomized, double-blind trial was conducted in 60 patients that completed all requirements. This study was conducted in the Department of Otolaryngology and Orthopedics, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran, between December 2007 and November 2008. The patients were divided into 2 groups, the experimental and the control groups that were similar with respect to gender, age, and weight. The treatment group received 1.5 g/day (500 mg every 8 hours) Aspirin, and the control group received placebo similar to the other group.
Results:
Comparison of the pure tone audiometry (PTA) at 1000 Hertz (Hz) (p=0.03), 2000 Hz (p=0.003), 4000 Hz (p=0.001), and 8000 Hz (p=0.0010) showed significant differences between mean of PTA at the beginning, 8th, and 15th day. The threshold of PTA at 250 Hz was significantly different only at the 8th and 15th day (p=0.004), also at the frequency of 500 Hz, the difference between the beginning within 15th day and 8th day with 15th day was significant (p=0.001).
Conclusion:
In the present study, we had shown that Aspirin can protect the ototoxic effect of gentamicin in patients.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
09:06Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Inhibitors of Bacterial Protein Synthesis
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug toxicity: Drug–Drug Interaction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase